Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Discovery

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1919679

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1919679

Drug Discovery Informatics Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global Drug Discovery Informatics Market is rapidly evolving as an essential pillar of pharmaceutical and biotechnology research, providing advanced solutions to accelerate drug development, optimize data management, and enhance R&D efficiency. Drug discovery informatics leverages computational platforms, data analytics, and AI-driven technologies to streamline the complex process of identifying, validating, and optimizing drug candidates.

Valued at USD 3.7 billion in 2026, the market is projected to reach USD 6.9 billion by 2033, growing at a robust CAGR of 9.40%. The increasing reliance on informatics tools to manage large datasets, improve molecular modeling, and facilitate predictive analytics is driving the market's growth globally.

Market Insights

Drug discovery informatics enables pharmaceutical and biotechnology companies to analyze complex biological, chemical, and clinical data, supporting faster and more accurate decision-making in the drug development process. The market's expansion is largely fueled by advancements in artificial intelligence (AI), machine learning (ML), and high-throughput computational platforms.

Cloud-based systems have become a game-changer, offering scalable, collaborative, and real-time access to research data. Integrating big data analytics into drug discovery workflows allows organizations to extract actionable insights from genomics, proteomics, and chemical libraries. This, in turn, improves efficiency, reduces errors, and shortens timelines for bringing new therapeutics to market.

Market Drivers

Several key factors are propelling the growth of the drug discovery informatics market:

  • 1. Rising R&D Investment: Increased expenditure by pharmaceutical and biotechnology firms to reduce development time and optimize research budgets.
  • 2. Technological Innovation: AI, ML, and advanced modeling platforms accelerate molecular docking, predictive analysis, and target validation.
  • 3. Demand for Personalized Medicine: Growing need for tailored therapies requires sophisticated informatics solutions to analyze patient-specific data.
  • 4. Regulatory Compliance and Data Management: Strict requirements for data integrity and reporting encourage adoption of advanced informatics systems.
  • 5. Collaborations and Outsourcing Trends: Strategic partnerships and outsourced services enable organizations to leverage expertise while lowering operational costs.

Business Opportunity

The market presents considerable opportunities for software providers, cloud-based service platforms, and consultancy firms specializing in drug discovery. By offering AI-driven analytics, predictive modeling, and tailored solutions, companies can support pharmaceutical R&D teams in reducing costs and accelerating timelines.

Outsourcing of drug discovery informatics services is gaining traction, especially among mid-sized and emerging pharma companies, creating avenues for service providers to expand. Additionally, emerging markets in Asia Pacific, Latin America, and the Middle East & Africa are increasingly adopting advanced drug discovery solutions, supported by growing biotech research, government incentives, and collaborations with global solution providers.

Regional Analysis

  • North America: Dominates the global market due to well-established pharmaceutical and biotechnology industries, high R&D spending, and early adoption of advanced informatics solutions.
  • Europe: Growth is driven by strong biotech research hubs, government-backed innovation programs, and collaborations between pharma companies and informatics providers.
  • Asia Pacific: Rapidly emerging as a high-growth region due to increased investment in pharmaceutical R&D, expanding biotech ecosystem, and supportive government initiatives.
  • Latin America: Market growth is moderate but steady, with countries like Brazil and Mexico adopting informatics solutions to improve drug discovery efficiency.
  • Middle East & Africa: Growth is supported by developing healthcare infrastructure, rising pharma research activities, and adoption of cloud-based platforms.

Key Players

The market features established and emerging companies offering comprehensive informatics solutions, analytics tools, and cloud-based platforms. Leading players include:

  • Schrodinger, Inc.
  • Cresset Group
  • BIOVIA (Dassault Systemes)
  • Certara (formerly Tripos)
  • OpenEye Scientific
  • Genedata AG
  • Dotmatics (Cignpost Diagnostics)
  • ChemAxon (part of Optibrium)
  • Optibrium Ltd.
  • Benchling
  • Insilico Medicine
  • Exscientia
  • Schrodinger (also R&D informatics)
  • PerkinElmer, Inc.
  • BioSolveIT GmbH

These companies are actively investing in R&D, forming strategic partnerships, and expanding their global presence. Cloud-based platforms, AI integration, and collaborations with pharmaceutical firms are key strategies to maintain competitiveness and capitalize on market growth.

Market Segmentation

The drug discovery informatics market can be segmented based on service type, modality, application, end user, and region:

By Service Type

  • In-house
  • Outsourced

By Modality

  • Cloud-based Systems
  • In-campus Platform

By Application

  • Data Sequencing
  • Molecular Docking
  • Identification and Validation Informatics
  • Target Data Analysis
  • Others

By End User

  • Pharmaceutical Companies
  • Contract Research Organizations
  • Biotechnology Companies
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Drug Discovery Informatics Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Drug Discovery Informatics Market Outlook, 2020 - 2033

  • 3.1. Global Drug Discovery Informatics Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
    • 3.1.1. In-house
    • 3.1.2. Outsourced
  • 3.2. Global Drug Discovery Informatics Market Outlook, by Modality, Value (US$ Bn), 2020-2033
    • 3.2.1. Cloud-based Systems
    • 3.2.2. In-campus Platform
  • 3.3. Global Drug Discovery Informatics Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.3.1. Data Sequencing
    • 3.3.2. Molecular Docking
    • 3.3.3. Identification and Validation Informatics
    • 3.3.4. Target Data Analysis
    • 3.3.5. Others
  • 3.4. Global Drug Discovery Informatics Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.4.1. Pharmaceutical Companies
    • 3.4.2. Contract Research Organizations
    • 3.4.3. Biotechnology Companies
    • 3.4.4. Others
  • 3.5. Global Drug Discovery Informatics Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East & Africa

4. North America Drug Discovery Informatics Market Outlook, 2020 - 2033

  • 4.1. North America Drug Discovery Informatics Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
    • 4.1.1. In-house
    • 4.1.2. Outsourced
  • 4.2. North America Drug Discovery Informatics Market Outlook, by Modality, Value (US$ Bn), 2020-2033
    • 4.2.1. Cloud-based Systems
    • 4.2.2. In-campus Platform
  • 4.3. North America Drug Discovery Informatics Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.3.1. Data Sequencing
    • 4.3.2. Molecular Docking
    • 4.3.3. Identification and Validation Informatics
    • 4.3.4. Target Data Analysis
    • 4.3.5. Others
  • 4.4. North America Drug Discovery Informatics Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.4.1. Pharmaceutical Companies
    • 4.4.2. Contract Research Organizations
    • 4.4.3. Biotechnology Companies
    • 4.4.4. Others
  • 4.5. North America Drug Discovery Informatics Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.5.1. U.S. Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 4.5.2. U.S. Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 4.5.3. U.S. Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 4.5.4. U.S. Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 4.5.5. Canada Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 4.5.6. Canada Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 4.5.7. Canada Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 4.5.8. Canada Drug Discovery Informatics Market Outlook, by End User, 2020-2033
  • 4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Drug Discovery Informatics Market Outlook, 2020 - 2033

  • 5.1. Europe Drug Discovery Informatics Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
    • 5.1.1. In-house
    • 5.1.2. Outsourced
  • 5.2. Europe Drug Discovery Informatics Market Outlook, by Modality, Value (US$ Bn), 2020-2033
    • 5.2.1. Cloud-based Systems
    • 5.2.2. In-campus Platform
  • 5.3. Europe Drug Discovery Informatics Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.3.1. Data Sequencing
    • 5.3.2. Molecular Docking
    • 5.3.3. Identification and Validation Informatics
    • 5.3.4. Target Data Analysis
    • 5.3.5. Others
  • 5.4. Europe Drug Discovery Informatics Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.4.1. Pharmaceutical Companies
    • 5.4.2. Contract Research Organizations
    • 5.4.3. Biotechnology Companies
    • 5.4.4. Others
  • 5.5. Europe Drug Discovery Informatics Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.5.1. Germany Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 5.5.2. Germany Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 5.5.3. Germany Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 5.5.4. Germany Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 5.5.5. Italy Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 5.5.6. Italy Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 5.5.7. Italy Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 5.5.8. Italy Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 5.5.9. France Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 5.5.10. France Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 5.5.11. France Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 5.5.12. France Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 5.5.13. U.K. Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 5.5.14. U.K. Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 5.5.15. U.K. Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 5.5.16. U.K. Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 5.5.17. Spain Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 5.5.18. Spain Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 5.5.19. Spain Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 5.5.20. Spain Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 5.5.21. Russia Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 5.5.22. Russia Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 5.5.23. Russia Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 5.5.24. Russia Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 5.5.25. Rest of Europe Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 5.5.26. Rest of Europe Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 5.5.27. Rest of Europe Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 5.5.28. Rest of Europe Drug Discovery Informatics Market Outlook, by End User, 2020-2033
  • 5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Drug Discovery Informatics Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Drug Discovery Informatics Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
    • 6.1.1. In-house
    • 6.1.2. Outsourced
  • 6.2. Asia Pacific Drug Discovery Informatics Market Outlook, by Modality, Value (US$ Bn), 2020-2033
    • 6.2.1. Cloud-based Systems
    • 6.2.2. In-campus Platform
  • 6.3. Asia Pacific Drug Discovery Informatics Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.3.1. Data Sequencing
    • 6.3.2. Molecular Docking
    • 6.3.3. Identification and Validation Informatics
    • 6.3.4. Target Data Analysis
    • 6.3.5. Others
  • 6.4. Asia Pacific Drug Discovery Informatics Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.4.1. Pharmaceutical Companies
    • 6.4.2. Contract Research Organizations
    • 6.4.3. Biotechnology Companies
    • 6.4.4. Others
  • 6.5. Asia Pacific Drug Discovery Informatics Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.5.1. China Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 6.5.2. China Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 6.5.3. China Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 6.5.4. China Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 6.5.5. Japan Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 6.5.6. Japan Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 6.5.7. Japan Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 6.5.8. Japan Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 6.5.9. South Korea Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 6.5.10. South Korea Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 6.5.11. South Korea Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 6.5.12. South Korea Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 6.5.13. India Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 6.5.14. India Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 6.5.15. India Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 6.5.16. India Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 6.5.17. Southeast Asia Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 6.5.18. Southeast Asia Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 6.5.19. Southeast Asia Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 6.5.20. Southeast Asia Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 6.5.21. Rest of SAO Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 6.5.22. Rest of SAO Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 6.5.23. Rest of SAO Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 6.5.24. Rest of SAO Drug Discovery Informatics Market Outlook, by End User, 2020-2033
  • 6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Drug Discovery Informatics Market Outlook, 2020 - 2033

  • 7.1. Latin America Drug Discovery Informatics Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
    • 7.1.1. In-house
    • 7.1.2. Outsourced
  • 7.2. Latin America Drug Discovery Informatics Market Outlook, by Modality, Value (US$ Bn), 2020-2033
    • 7.2.1. Cloud-based Systems
    • 7.2.2. In-campus Platform
  • 7.3. Latin America Drug Discovery Informatics Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.3.1. Data Sequencing
    • 7.3.2. Molecular Docking
    • 7.3.3. Identification and Validation Informatics
    • 7.3.4. Target Data Analysis
    • 7.3.5. Others
  • 7.4. Latin America Drug Discovery Informatics Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.4.1. Pharmaceutical Companies
    • 7.4.2. Contract Research Organizations
    • 7.4.3. Biotechnology Companies
    • 7.4.4. Others
  • 7.5. Latin America Drug Discovery Informatics Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.5.1. Brazil Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 7.5.2. Brazil Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 7.5.3. Brazil Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 7.5.4. Brazil Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 7.5.5. Mexico Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 7.5.6. Mexico Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 7.5.7. Mexico Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 7.5.8. Mexico Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 7.5.9. Argentina Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 7.5.10. Argentina Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 7.5.11. Argentina Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 7.5.12. Argentina Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 7.5.13. Rest of LATAM Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 7.5.14. Rest of LATAM Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 7.5.15. Rest of LATAM Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 7.5.16. Rest of LATAM Drug Discovery Informatics Market Outlook, by End User, 2020-2033
  • 7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Drug Discovery Informatics Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Drug Discovery Informatics Market Outlook, by Service Type, Value (US$ Bn), 2020-2033
    • 8.1.1. In-house
    • 8.1.2. Outsourced
  • 8.2. Middle East & Africa Drug Discovery Informatics Market Outlook, by Modality, Value (US$ Bn), 2020-2033
    • 8.2.1. Cloud-based Systems
    • 8.2.2. In-campus Platform
  • 8.3. Middle East & Africa Drug Discovery Informatics Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.3.1. Data Sequencing
    • 8.3.2. Molecular Docking
    • 8.3.3. Identification and Validation Informatics
    • 8.3.4. Target Data Analysis
    • 8.3.5. Others
  • 8.4. Middle East & Africa Drug Discovery Informatics Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.4.1. Pharmaceutical Companies
    • 8.4.2. Contract Research Organizations
    • 8.4.3. Biotechnology Companies
    • 8.4.4. Others
  • 8.5. Middle East & Africa Drug Discovery Informatics Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.5.1. GCC Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 8.5.2. GCC Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 8.5.3. GCC Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 8.5.4. GCC Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 8.5.5. South Africa Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 8.5.6. South Africa Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 8.5.7. South Africa Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 8.5.8. South Africa Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 8.5.9. Egypt Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 8.5.10. Egypt Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 8.5.11. Egypt Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 8.5.12. Egypt Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 8.5.13. Nigeria Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 8.5.14. Nigeria Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 8.5.15. Nigeria Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 8.5.16. Nigeria Drug Discovery Informatics Market Outlook, by End User, 2020-2033
    • 8.5.17. Rest of Middle East Drug Discovery Informatics Market Outlook, by Service Type, 2020-2033
    • 8.5.18. Rest of Middle East Drug Discovery Informatics Market Outlook, by Modality, 2020-2033
    • 8.5.19. Rest of Middle East Drug Discovery Informatics Market Outlook, by Application, 2020-2033
    • 8.5.20. Rest of Middle East Drug Discovery Informatics Market Outlook, by End User, 2020-2033
  • 8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Schrodinger, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Cresset Group
    • 9.4.3. BIOVIA (Dassault Systemes)
    • 9.4.4. Certara (formerly Tripos)
    • 9.4.5. OpenEye Scientific
    • 9.4.6. Genedata AG
    • 9.4.7. Dotmatics (Cignpost Diagnostics)
    • 9.4.8. ChemAxon (part of Optibrium)
    • 9.4.9. Optibrium Ltd.
    • 9.4.10. Benchling

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!